Tuesday, June 30, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

ETON — Eton Pharmaceuticals, Inc. SEC Filings | FilingIndex

ETONNasdaq

Eton Pharmaceuticals, Inc.

Pharmaceutical Preparations · DE · CIK 1710340

Eton Pharmaceuticals develops and commercializes treatments for rare diseases

red 8-K · 90d

+ Watch View on EDGAR ↗

$865M

Market cap

$36.73

Last close

+2.9%

1D

+12.3%

5D

667K

Volume

Price · last 39 sessions+21.8%

May 4L $27.40 · H $36.73Jun 29

204

Total filings

Jun 9, 2026

Last filing

12/31

Fiscal year end

All 8-K · 143 10-Q · 23 DEF 14A · 8 10-K · 8 424B5 · 4 S-1/A · 4 SC 13G · 4 8-K/A · 4

8-KShareholder VoteJun 9, 2026 8-KMaterial Agreement · Acquisition / DispositionMay 19, 2026 10-QFORM 10-QMay 14, 2026 8-KResults of OperationsMay 14, 2026 8-KCompany UpdateMay 1, 2026 8-K

Similar companies

Comparable business profile · signals at a glance

TVTXTravere Therapeutics, Inc.$4.8B-0.9%XERSXeris Biopharma Holdings, Inc.$1.2B+0.7%MIRMMirum Pharmaceuticals, Inc.$6.1B-0.6%PLXProtalix BioTherapeutics, Inc.$168.4M+2.2%CRNXCrinetics Pharmaceuticals, Inc.

Company Update

Apr 27, 2026

DEF 14AFORM DEF 14AApr 24, 2026

8-KExecutive Change · Reg FD DisclosureApr 16, 2026

8-KMaterial Agreement · New Debt / ObligationApr 15, 2026

10-KFORM 10-KMar 19, 2026

8-KResults of OperationsMar 19, 2026

8-KMaterial Agreement · Acquisition / DispositionMar 2, 2026

8-KCompany UpdateFeb 25, 2026

8-KCompany UpdateFeb 2, 2026

8-KReg FD DisclosureDec 4, 2025

8-K/AAcquisition / DispositionNov 18, 2025

10-QFORM 10-QNov 6, 2025

8-KResults of OperationsNov 6, 2025

10-QFORM 10-QAug 7, 2025

8-KResults of OperationsAug 7, 2025

8-KCompany UpdateJul 8, 2025

8-KCompany UpdateJun 27, 2025

8-KAuditor ChangeJun 20, 2025

8-KShareholder VoteJun 10, 2025

8-KCompany UpdateMay 28, 2025

10-QFORM 10-QMay 13, 2025

8-KResults of OperationsMay 13, 2025

8-K/AAcquisition / Disposition · Company UpdateMay 2, 2025

8-KCompany UpdateApr 28, 2025

DEF 14AFORM DEF 14AApr 25, 2025

8-KCompany UpdateApr 1, 2025

8-KReg FD DisclosureMar 18, 2025

8-KResults of OperationsMar 18, 2025

10-KFORM 10-KMar 18, 2025

8-KCompany UpdateMar 14, 2025

8-K/AAcquisition / Disposition · Company UpdateMar 7, 2025

8-KCompany UpdateMar 3, 2025

8-KCompany UpdateFeb 7, 2025

8-KCompany UpdateFeb 6, 2025

8-KAcquisition / DispositionJan 3, 2025

8-KAcquisition / DispositionDec 20, 2024

8-KCompany UpdateDec 17, 2024

8-KMaterial AgreementDec 12, 2024

424B5FORM 424B5Dec 12, 2024

SC 13GSC 13GDec 9, 2024

8-KCompany UpdateDec 3, 2024

8-KMaterial AgreementNov 25, 2024

10-QFORM 10-QNov 12, 2024

8-KResults of OperationsNov 12, 2024

8-KCompany UpdateNov 7, 2024

8-KMaterial AgreementOct 3, 2024

10-QFORM 10-QAug 8, 2024

8-KResults of OperationsAug 8, 2024

8-K/AShareholder VoteAug 2, 2024

8-KCompany UpdateJul 15, 2024

8-KAuditor ChangeJun 21, 2024

8-KShareholder VoteJun 11, 2024

10-QFORM 10-QMay 9, 2024

8-KResults of OperationsMay 9, 2024

8-KCompany UpdateApr 30, 2024

DEF 14AFORM DEF 14AApr 26, 2024

8-KEquity IssuanceApr 18, 2024

10-K/AFORM 10-K/AMar 22, 2024

8-KCompany UpdateMar 22, 2024

10-KFORM 10-KMar 14, 2024

8-KResults of OperationsMar 14, 2024

8-KCompany UpdateFeb 21, 2024

8-KCompany UpdateFeb 2, 2024

10-QFORM 10-QNov 9, 2023

8-KResults of OperationsNov 9, 2023

8-KCompany UpdateOct 4, 2023

10-QFORM 10-QAug 10, 2023

8-KResults of OperationsAug 10, 2023

8-KAgreement TerminatedJul 5, 2023

8-KCompany UpdateJun 28, 2023

8-KMaterial AgreementJun 15, 2023

8-KShareholder VoteJun 13, 2023

10-QFORM 10-QMay 11, 2023

8-KResults of OperationsMay 11, 2023

8-KCompany UpdateMay 10, 2023

$3.6B

+0.7%

RZLTRezolute, Inc.$385.2M+1.2%